BioSpace News Archive

Loki Therapeutics, an immuno-oncology company developing next-generation cancer therapeutics that leverage childhood vaccination recall antigens, announced its Chief Executive Officer Chris Bradley will present at the BIO CEO & Investor Digital Conference taking place February 16-18, 2021.

Momentus Inc. (“Momentus” or the “Company”), a commercial space company offering in-space infrastructure services, and Xona Space Systems, a San Mateo-based startup creating a secure and precise Position, Navigation, and Timing (PNT) satellite service, today announced a service agreement to advance Xona’s 2022 Alpha mission.

Dexcom Ventures to identify and invest in transformational technologies to advance long-term growth

OTIVIDEX ® Phase 3 trial results in Ménière’s disease expected by end of February OTO-313 Phase 2 trial in tinnitus planned to start in first quarter of 2021 with top-line results expected in mid-2022 OTO-413 Phase 1/2 trial expansion in hearing loss expected to start in second quarter of 2021 with results anticipated in mid-2022 Conference call and webcast today at 4:30 p.m. ET

Helio Health, an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced its participation in the 10 th Annual SVB Leerink Global Healthcare Conference, which takes place February 22-26, 2021 .

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today that management will participate in a fireside chat at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021 at 12:00 p.m. ET.

Eli Lilly and Company will participate in the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021.

Multiple clinical studies anticipated to launch in Calendar 2021, notably pivotal Phase 3 clinical studies of PH94B as a potential acute treatment of anxiety in adults with social anxiety disorder (SAD) Strengthened Balance Sheet upon closing of $100 million underwritten public offering

Located in Framingham, MA, Azzur Labs Boston provides analytical testing services to GMP manufacturers, as well as the cell and gene therapy industry and specialty pharmacies

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in a fireside chat during the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference, Friday, February 19, 2021 at 9:30 a.m. ET.